Critical Care

official impact factor 4.60

Open Access Highly Access

Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome

Saad Nseir*, Christophe Di Pompeo, Hélène Brisson, Florent Dewavrin, Stéphanie Tissier, Maimouna Diarra, Marie Boulo and Alain Durocher

Critical Care 2006, 10:R143 doi:10.1186/cc5063

Accesses  

  • Last 30 days: 261 accesses
  • Last year: 2438 accesses
  • All time: 11801 accesses

Cited by

BioMed Central: 2 citations

Research   Open Access Highly Accessed

Remifentanil discontinuation and subsequent intensive care unit-acquired infection: a cohort study

Saad Nseir, Jérémy Hoel, Guillaume Grailles, Aude Soury-Lavergne, Christophe Di Pompeo, Daniel Mathieu, Alain Durocher Critical Care 2009, 13:R60 (21 April 2009)

Remifentanil discontinuation is associated with an increased risk of ICU-acquired infection, an observation that reiterates previous reports on the negative effects of opioid withdrawal on the immune system.

Research   Open Access Highly Accessed

Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study

Saad Nseir, Raphaël Favory, Elsa Jozefowicz, Franck Decamps, Florent Dewavrin, Guillaume Brunin, Christophe Di Pompeo, Daniel Mathieu, Alain Durocher, Critical Care 2008, 12:R62 (2 May 2008)